Bystander effects of nucleoside analogs phosphorylated in the cytosol or mitochondria.
The efficiency of nucleoside kinase suicide gene therapy for cancer is highly dependent on "bystander" cell killing, i.e., the transfer of cytotoxic phosphorylated nucleoside analogs to cells adjacent to those expressing the suicide enzyme. We have recently studied the possible use of mitochondrial nucleoside kinases as suicide genes. In the present study, we investigated if nucleoside analogs phosphorylated in the mitochondrial matrix cause bystander killing. We used deoxycytidine kinase-deficient Chinese hamster ovary cells reconstituted with deoxycytidine kinase targeted to either the cytosol or mitochondria matrix and determined the bystander cell killing when these cells were incubated with the nucleoside analogs 1-beta-D-arabinofuranosylcytosine and 2',2'-difluorodeoxycytidine. A bystander effect occurred when nucleoside analogs were phosphorylated in the cytosol, but not when these compounds were phosphorylated in the mitochondria. These findings suggest that nucleoside kinases targeted to the mitochondrial matrix have limited use in suicide gene therapy when efficient bystander cell killing is required.
Sanda
A
A
Karolinska Institute, Huddinge University Hospital, Stockholm, S-141 86, Sweden.
Zhu
C
C
Johansson
M
M
Karlsson
A
A
D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D003561:Cytarabine / Q000378:metabolism; D003600:Cytosol / Q000378:metabolism*; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000378:metabolism; D003842:Deoxycytidine Kinase / Q000378:metabolism*; D015316:Genetic Therapy / Q000379:methods*; D008928:Mitochondria / Q000378:metabolism*; D009369:Neoplasms / Q000628:therapy*; D009705:Nucleosides / Q000378:metabolism*; D010766:Phosphorylation; D000093542:Gemcitabine
D009705:Nucleosides; D003561:Cytarabine; D003841:Deoxycytidine; D003842:Deoxycytidine Kinase; D000093542:Gemcitabine